The inhibitory effect of both inhibitors on the PI3K pathway was investigated by immunoblotting key proteins of the pathway in two HPV-positive (SCC154, SCC104) and two HPV-negative (SQD9, SCC61) HNSCC cell lines. The gene discussed is PIK3CA; the disease is head and neck squamous cell carcinoma.